Abstract—
Molecular docking of four isoniazid hydrazones including steroids dehydroepiandrosterone, pregnenolone, 16α,17α-epoxypregnenolone, and cholestenone (IDHEA, IPRE, IEP5, ICHN), to mycobacterial cytochromes P450 was performed. The in silico study has shown than these hydrazones can be effectively bound to CYP121, CYP124, CYP125, CYP126A1, CYP130, and CYP51 with the calculated binding energy values ranged from –9 kcal/mol to –12 kcal/mol. Calculations also demonstrated that passive lipid bilayer permeability was higher than that of with isoniazid. In vitro IDHEA, IPRE, IEPR were found to undergo bioconversion into their 3-keto-4-en derivatives. This suggests their ability to penetrate into M. tuberculosis H37Rv cells. The results of this study are important in the context of understanding of binding specificity of synthetic steroid derivatives to mycobacterial CYPs and indicate the possibility of using these steroid compounds as new ligands for these enzymes.
Similar content being viewed by others
REFERENCES
MacNeil, A., Glaziou, P., Sismanidis, C., Date, A., Maloney, S., and Floyd, K., MMWR Morb. Mortal W-kly. Rep., 2020, vol. 69, pp. 281–285. https://doi.org/10.15585/mmwr.mm6911a2
Cui, Z.J., Zhang, W.T., Zhu, Q., Zhang, Q.Y., and Zhang, H.Y., Protein Pept. Lett., 2020.https://doi.org/10.2174/0929866527666200313113157
Reis, W.J., Bozzi, Í.A.O., Ribeiro, M.F., Halicki, P.C.B., Ferreira, L.A., Almeida da Silva, P.E., Ramos, D.F., de Simone, C.A., and da Silva Júnior, E.N., Bioorg. Med. Chem., 2019, vol. 27, pp. 4143–4150. https://doi.org/10.1016/j.bmc.2019.07.045
Vosátka, R., Krátký, M., Švarcová, M., Janoušek, J., Stolaříková, J., Madacki, J., Huszár, S., Mikušová, K., Korduláková, J., Trejtnar, F., and Vinšová, J., Eur. J. Med. Chem., 2018, vol. 151, pp. 824–835. https://doi.org/10.1016/j.ejmech.2018.04.017
Bonds, A.C. and Sampson, N.S., Curr. Opin. Chem. -Biol., 2018, vol. 44, pp. 39–46. https://doi.org/10.1016/j.cbpa.2018.05.012
Frank, D.J., Zhao, Y., Wong, S.H., Basudhar, D., de Voss, J.J., and Ortiz de Montellano, P.R., J. Biol. Chem., 2016, vol. 291, pp. 7325–7333. https://doi.org/10.1074/jbc.M115.708172
Ortega Ugalde, S., Boot, M., Commandeur, J.N.M., Jennings, P., Bitter, W., and Vos, J.C., Appl. Microbiol. Biotechnol., 2019, vol. 9, pp. 3597–3614. https://doi.org/10.1007/s00253-019-09697-z
Brzezinska, M., Szulc, I., Brzostek, A., Klink, M., Kielbik, M., Sulowska, Z., Pawelczyk, J., and Dziadek, J., BMC Microbiol., 2013, vol. 13, 43. https://doi.org/10.1186/1471-2180-13-43
Hu, Y., van der Geize, R., Besra, G.S., Gurcha, S.S., Liu, A., Rohde, M., Singh, M., and Coates, A., Mol. Microbiol., 2010, vol. 75, pp. 107–121. https://doi.org/10.1111/j.1365-2958.2009.06957.x
Poroikov, V.V., Biomeditsinskaya Khimiya, 2020, vol. 66, no. 1, pp. 30–41. https://doi.org/10.18097/PBMC20206601030
Ershov, P.V., Yablokov, E.O., Mezentsev, Y.V., Kalushskiy, L.A., Florinskaya, A.V., Veselovsky, A.V., Gnedenko, O.V., Gilep, A.A., Usanov, S.A., Medvedev, A.E., and Ivanov, A.S., Biomeditsinskaya Khimiya, 2017, vol. 63, no. 2, pp. 170–175. https://doi.org/10.18097/PBMC20176302170
Panada, J.U., Faletrov, Y.V., Frolova, N.S., and Shkumatov, V.M., Biomeditsinskaya Khimiya, 2019, vol. 65, no. 4, pp. 324–330. https://doi.org/10.18097/PBMC20196504324
Trott, O. and Olson, A.J., J. Comput. Chem., 2010, vol. 31, pp. 455–461. https://doi.org/10.1002/jcc.21334
Lomize, A.L., Hage, J.M., Schnitzer, K., Golobokov, K., LaFaive, M.B., Forsyth, A.C., and Pogozheva, I.D., J. Chem. Inf. Model., 2019, vol. 59, pp. 3094–3099. https://doi.org/10.1021/acs.jcim.9b00225
Lavrynenko, O., Nedielkov, R., Möller, H.M., and Shevchenko, A., J. Lipid Res., 2013, vol. 54, pp. 2265–2272. https://doi.org/10.1194/jlr.D035949
McLean, K.J., Lafite, P., Levy, C., Cheesman, M.R., Mast, N., Pikuleva, I.A., Leys, D., and Munro, A., J. Biol. Chem., 2009, vol. 284, pp. 35524–35533. https://doi.org/10.1074/jbc.M109.032706
Ortega Ugalde, S., Boot, M., Commandeur, J.N.M., Jennings, P., Bitter, W., and Vos, J.C., Appl. Microbiol. Biotechnol., 2019, vol. 9, pp. 3597–3614. https://doi.org/10.1007/s00253-019-09697-z
Sampiron, E.G., Costacurta, G.F., Baldin, V.P., Almeida, A.L., Ieque, A.L., Santos, N.C., Alves-Olher, V.G., Vandresen, F., Gimenes, A.C., Siqueira, V.L., Caleffi-Ferracioli, K.R., Cardoso, R.F., and Scodro, R.B., Future Microbiol., 2019, vol. 14, pp. 981–994. https://doi.org/10.2217/fmb-2019-0040
Merlani, M.I., Kemertelidze, E.P., Papadopoulos, K., and Men’shova, N.I., Rus. J. Bioorg. Chem., 2004, vol. 30, pp. 497–501. https://doi.org/10.1023/B:RUBI.0000043795.25417.60
Guengerich, F.P. and Munro, A.W., J. Biol. Chem., 2013, vol. 288, pp. 17065–17073. https://doi.org/10.1074/jbc.R113.462275
Hong, X. and Hopfinger, A.J., Biomacromolecules, 2004, vol. 5, pp. 1066–1077. https://doi.org/10.1021/bm03145155
Sinha, R., Singh, P., Saini, N.K., et al., Tuberculosis (Edinb.), 2018, vol. 109, pp. 52–60. https://doi.org/10.1016/j.tube.2018.01.004
Faletrov, Y., Brzostek, A., Plocinska, R., Dziadek, J., Rudaya, E., Edimecheva, I., and Shkumatov, V., Steroids, 2017, vol. 117, pp. 29–37. https://doi.org/10.1016/j.steroids.2016.10.001
Yang, X., Dubnau, E., Smith, I., and Sampson, N.S., Biochemistry, 2007, vol. 46, pp. 9058–9067. https://doi.org/10.1021/bi700688x
ACKNOWLEDGMENTS
The authors are grateful to the staff of the Department of Radiation Chemistry and Chemical-Pharmaceutical Technologies and the Department of Organic Chemistry (Faculty of Chemistry, Belarusian State University) for the opportunity to perform mass spectrometric and IR spectroscopic analysis.
Funding
This work was supported by the Belarusian Foundation for Basic Research (project no. B18MS-026).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
This article does not contain a description of the research performed by the authors with the participation of humans or the use of animals as research objects.
CONFLICT OF INTEREST
K.A. Gilep and A.S. Falchevskaya participated in the synthesis of the studied hydrazones and testing the interaction with CYP125 as a part of their graduation theses at the Faculty of Chemistry of BSU in 2019 under supervision by V.M. Shkumatov and Ya.V. Faletrov, respectively. The authors are grateful to Dr. A.A. Gilep for constant help in isolation of a purified mycobacterial CYP125 preparation. Other authors postulate the absence of potential conflicts associated with the publication of this material.
Additional information
Translated by A. Medvedev
Rights and permissions
About this article
Cite this article
Faletrov, Y.V., Gilep, K.A., Falchevskaya, A.S. et al. In Silico Modeling of Isoniazid-Steroid Conjugates Interactions with Mycobacterial Cytochromes P450 and Their Bioconversion in Vitro by the Cells. Biochem. Moscow Suppl. Ser. B 15, 111–118 (2021). https://doi.org/10.1134/S1990750821020037
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750821020037